Net Cash Provided by (Used in) Financing Activities in USD of Protara Therapeutics, Inc. from 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Protara Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2015 to Q1 2025.
  • Protara Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.73M.
  • Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $140M.
  • Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$91K, a 1.11% decline from 2022.
  • Protara Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$90K, a 60.5% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.73M +$1.81M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 -$76K -$12K -18.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 -$64K +$8K +11.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$72K +$156K +68.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 -$228K -$39.5M -101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $39.2M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2017 $213K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09

Protara Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $140M* +$140M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 -$91K -$1K -1.11% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 -$90K +$138K +60.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$228K -$417K -220% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $189K -$311K -62.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $500K -$2.49M -83.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $2.99M -$20.1M -87% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $23M +$22.8M +10981% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $208K +$45K +27.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $163K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.